$BDPT
BIOADAPTIVES, INC.

2023 Q3 Form 10-Q Financial Statement

#000164033423001531 Filed on August 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $15.65K $2.339K
YoY Change 368.95% -45.88%
Cost Of Revenue $11.00K $849.00
YoY Change 722.66% -60.86%
Gross Profit $4.650K $1.490K
YoY Change 132.5% -30.79%
Gross Profit Margin 29.71% 63.7%
Selling, General & Admin $59.22K $56.76K
YoY Change -20.58% -53.33%
% of Gross Profit 1273.55% 3809.4%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $37.64K $680.00
YoY Change 742.06% -97.15%
% of Gross Profit 809.46% 45.64%
Operating Expenses $96.86K $57.44K
YoY Change 22.54% -60.51%
Operating Profit -$92.21K -$55.95K
YoY Change 19.69% -60.96%
Interest Expense $20.63K $52.25K
YoY Change -78.08% -30.67%
% of Operating Profit
Other Income/Expense, Net $79.15K -$87.97K
YoY Change -139.72% 9.22%
Pretax Income -$13.06K -$143.9K
YoY Change -95.27% -35.7%
Income Tax
% Of Pretax Income
Net Earnings -$13.06K -$143.9K
YoY Change -95.27% -35.7%
Net Earnings / Revenue -83.46% -6152.93%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 776.5M shares 384.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $152.1K $40.14K
YoY Change 747.71% -19.04%
Cash & Equivalents $152.1K $40.12K
Short-Term Investments $10.00 $20.00
Other Short-Term Assets
YoY Change
Inventory $7.250K $6.487K
Prepaid Expenses
Receivables $3.340K
Other Receivables $0.00
Total Short-Term Assets $162.7K $46.63K
YoY Change 527.1% -23.84%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $166.6K $1.644K
YoY Change 4435.25% -79.83%
TOTAL ASSETS
Total Short-Term Assets $162.7K $46.63K
Total Long-Term Assets $166.6K $1.644K
Total Assets $329.3K $48.27K
YoY Change 1011.94% -30.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.344K $1.394K
YoY Change -37.38% -44.31%
Accrued Expenses $126.3K $1.419K
YoY Change 4716.7% -54.9%
Deferred Revenue
YoY Change
Short-Term Debt $333.2K $377.0K
YoY Change -23.25% -16.26%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.475M $1.727M
YoY Change -9.25% 10.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.475M $1.727M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.475M $1.727M
YoY Change -9.25% 10.39%
SHAREHOLDERS EQUITY
Retained Earnings -$7.996M -$7.983M
YoY Change 6.28% 10.15%
Common Stock $77.65K $57.65K
YoY Change 484.08% 644.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.146M -$1.679M
YoY Change
Total Liabilities & Shareholders Equity $329.3K $48.27K
YoY Change 1011.94% -30.42%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$13.06K -$143.9K
YoY Change -95.27% -35.7%
Depreciation, Depletion And Amortization $37.64K $680.00
YoY Change 742.06% -97.15%
Cash From Operating Activities -$56.15K -$56.87K
YoY Change -15.7% -21.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 168.1K 91.04K
YoY Change 380.29% 38.53%
NET CHANGE
Cash From Operating Activities -56.15K -56.87K
Cash From Investing Activities
Cash From Financing Activities 168.1K 91.04K
Net Change In Cash 111.9K 34.17K
YoY Change -454.16% -644.98%
FREE CASH FLOW
Cash From Operating Activities -$56.15K -$56.87K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
42512 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-287187 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1630652 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
96057 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1398153 usd
CY2022Q4 us-gaap Assets
Assets
37314 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
409920 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
686856 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1488815 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6074763 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7551679 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1451501 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37314 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001575142
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1250000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
252554765 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
576474023 shares
CY2022Q4 bdpt Common Stock Capital Shares Reserved For Future Issuance1
CommonStockCapitalSharesReservedForFutureIssuance1
10000 shares
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Entity File Number
EntityFileNumber
000-54949
dei Entity Registrant Name
EntityRegistrantName
BioAdaptives Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2592228
dei Entity Address Address Line1
EntityAddressAddressLine1
2620 Regatta Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 102
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89128
dei City Area Code
CityAreaCode
702
dei Local Phone Number
LocalPhoneNumber
659-8829
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
776464023 shares
CY2023Q2 us-gaap Assets Current
AssetsCurrent
46629 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
34324 usd
CY2023Q2 us-gaap Indefinite Lived License Agreements
IndefiniteLivedLicenseAgreements
1644 usd
CY2022Q4 us-gaap Indefinite Lived License Agreements
IndefiniteLivedLicenseAgreements
2990 usd
CY2023Q2 us-gaap Assets
Assets
48273 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
419685 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
930072 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
7647 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
315738 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
381793 usd
CY2023Q2 bdpt Notes Payable Related Parties Classified As Current
NotesPayableRelatedPartiesClassifiedAsCurrent
61290 usd
CY2022Q4 bdpt Notes Payable Related Parties Classified As Current
NotesPayableRelatedPartiesClassifiedAsCurrent
10246 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1726785 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1726785 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1488815 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1250000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
576474023 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
252554765 shares
CY2023Q2 bdpt Common Stock Capital Shares Reserved For Future Issuance1
CommonStockCapitalSharesReservedForFutureIssuance1
10000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
57647 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
25255 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6246464 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7982783 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1678512 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48273 usd
CY2023Q2 us-gaap Revenues
Revenues
2339 usd
CY2022Q2 us-gaap Revenues
Revenues
4322 usd
us-gaap Revenues
Revenues
5715 usd
us-gaap Revenues
Revenues
9855 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
849 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
2169 usd
us-gaap Cost Of Revenue
CostOfRevenue
2245 usd
us-gaap Cost Of Revenue
CostOfRevenue
5759 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
1490 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
2153 usd
us-gaap Gross Profit
GrossProfit
3470 usd
us-gaap Gross Profit
GrossProfit
4096 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14516 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
87517 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26552 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
192717 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
42246 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
34112 usd
us-gaap Professional Fees
ProfessionalFees
50496 usd
us-gaap Professional Fees
ProfessionalFees
71944 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
677 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23821 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1346 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
56988 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
57439 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
145450 usd
us-gaap Operating Expenses
OperatingExpenses
78394 usd
us-gaap Operating Expenses
OperatingExpenses
321649 usd
CY2023Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-10 usd
CY2022Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-106 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-20 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-127 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
52253 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
75367 usd
us-gaap Interest Expense
InterestExpense
103316 usd
us-gaap Interest Expense
InterestExpense
105466 usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-35705 usd
CY2022Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-5067 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-252844 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-167822 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-87968 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-80540 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-356180 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-273415 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-143917 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-223837 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-431104 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-590968 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-143917 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-223837 usd
us-gaap Net Income Loss
NetIncomeLoss
-431104 usd
us-gaap Net Income Loss
NetIncomeLoss
-590968 usd
CY2023Q2 bdpt Basic And Diluted Earning Per Share
BasicAndDilutedEarningPerShare
-0.00
CY2022Q2 bdpt Basic And Diluted Earning Per Share
BasicAndDilutedEarningPerShare
-0.00
bdpt Basic And Diluted Earning Per Share
BasicAndDilutedEarningPerShare
-0.00
bdpt Basic And Diluted Earning Per Share
BasicAndDilutedEarningPerShare
-0.01
CY2023Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
441742955 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
67545413 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
355268125 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
60677388 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1451501 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-143917 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1678512 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1093039 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
52017 usd
CY2022Q1 bdpt Debts Forgiveness Related Party
DebtsForgivenessRelatedParty
10000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-367131 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
121615 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual Additions From Business Acquisition
StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition
5429 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-223837 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1494946 usd
us-gaap Profit Loss
ProfitLoss
431104 usd
us-gaap Profit Loss
ProfitLoss
590968 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
252844 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
162755 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1346 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
56988 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
82385 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
79547 usd
bdpt Unrealized Gain And Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainAndLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-21 usd
bdpt Unrealized Gain And Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainAndLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-127 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2390 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5897 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
15790 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
157431 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
0 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
1803 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-76328 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-138214 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
51044 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1623 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1623 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
25272 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
40000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
125000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
91044 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
99728 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
14716 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-38486 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25405 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82936 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40121 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44450 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
4728 usd
us-gaap Separate Account Liability Period Increase Decrease
SeparateAccountLiabilityPeriodIncreaseDecrease
110000 usd
us-gaap Separate Account Liability Period Increase Decrease
SeparateAccountLiabilityPeriodIncreaseDecrease
92000 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
204093 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
173632 usd
bdpt Debts Forgiveness Related Party
DebtsForgivenessRelatedParty
0 usd
bdpt Debts Forgiveness Related Party
DebtsForgivenessRelatedParty
10000 usd
us-gaap Standard Product Warranty Accrual Additions From Business Acquisition
StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition
0 usd
us-gaap Standard Product Warranty Accrual Additions From Business Acquisition
StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition
5429 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of consolidated financial statements in conformity with US GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. These estimates and judgments are based on historical information, information that is currently available to the Company, and on various other assumptions that the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates.</p>
CY2023Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
21 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
930072 usd
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
42 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
686856 usd
CY2023Q2 bdpt Retained Earning Accumulated Deficit
RetainedEarningAccumulatedDeficit
-7982783 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1394 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6939 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
300000 usd
CY2023Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
300000 usd
CY2023Q2 bdpt Accrued Interest Current
AccruedInterestCurrent
116872 usd
CY2022Q4 bdpt Accrued Interest Current
AccruedInterestCurrent
101966 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1419 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1015 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
419685 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
409920 usd
CY2023Q2 bdpt Total Convertible Notes Payable
TotalConvertibleNotesPayable
358250 usd
CY2022Q4 bdpt Total Convertible Notes Payable
TotalConvertibleNotesPayable
389440 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
42512 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
7647 usd
CY2023Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
315738 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
381793 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
315738 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
381793 usd
CY2023Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
20763 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
25556 usd
CY2023Q2 bdpt Convertible Notes Accrued Interest
ConvertibleNotesAccruedInterest
115656 usd
CY2022Q4 bdpt Convertible Notes Accrued Interest
ConvertibleNotesAccruedInterest
100919 usd
bdpt Amortization Of Debt Discount
AmortizationOfDebtDiscount
82385 usd
bdpt Amortization Of Debt Discount
AmortizationOfDebtDiscount
79547 usd
us-gaap Debt Instrument Convertible If Converted Value In Excess Of Principal
DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
78440 usd
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
6026 usd
bdpt Convertible Shares Of Common Stock
ConvertibleSharesOfCommonStock
323919258 shares
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
64258 usd
bdpt Value Assigned Of Derivatives Liabilities
ValueAssignedOfDerivativesLiabilities
569854 usd
bdpt Debt Discount
DebtDiscount
117250 usd
bdpt Derivative Loss On Derivative1
DerivativeLossOnDerivative1
459854 usd
us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate
0 pure
CY2021 us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate
0 pure
bdpt Beginning Balance
BeginningBalance
686856 usd
bdpt Addition Of New Derivatives Recognized As Debt Discounts
AdditionOfNewDerivativesRecognizedAsDebtDiscounts
110000 usd
bdpt Addition Of New Derivatives Recognized As Loss On Derivatives
AdditionOfNewDerivativesRecognizedAsLossOnDerivatives
459854 usd
bdpt Settled On Issuance Of Common Stock
SettledOnIssuanceOfCommonStock
-119628 usd
bdpt Gain Loss On Change In Fair Value Of The Derivative Liabilities
GainLossOnChangeInFairValueOfTheDerivativeLiabilities
-207010 usd
bdpt Ending Balance
EndingBalance
930072 usd
bdpt Loss On Derivative Instruments Related Convertible Notes
LossOnDerivativeInstrumentsRelatedConvertibleNotes
459854 usd
bdpt Loss On Derivative Instruments Related Convertible Notes
LossOnDerivativeInstrumentsRelatedConvertibleNotes
28960 usd
bdpt Gain Loss On Change In Fair Value Of The Derivative Liabilities
GainLossOnChangeInFairValueOfTheDerivativeLiabilities
-207010 usd
bdpt Gain Loss On Change In Fair Value Of The Derivative Liabilities
GainLossOnChangeInFairValueOfTheDerivativeLiabilities
138862 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
252844 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
167822 usd
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1250000000 shares
CY2023Q2 bdpt Common Stock Capital Shares Reserved For Future Issuance1
CommonStockCapitalSharesReservedForFutureIssuance1
10000 shares
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
323919258 shares
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
204093 usd
CY2022Q1 us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
0.006
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5429 usd
us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1
P2Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.35 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0131 pure
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
30000 usd
us-gaap Interest Paid
InterestPaid
168 usd
us-gaap Interest Paid
InterestPaid
363 usd
CY2023Q2 bdpt Notes Payable To Related Parties Noncurrent
NotesPayableToRelatedPartiesNoncurrent
8444 usd
CY2022Q4 bdpt Notes Payable To Related Parties Noncurrent
NotesPayableToRelatedPartiesNoncurrent
8444 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
1214 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1047 usd
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.04 pure
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 bdpt Amount Receive From Initial Wholesale Order
AmountReceiveFromInitialWholesaleOrder
9000 usd

Files In Submission

Name View Source Status
0001640334-23-001531-index-headers.html Edgar Link pending
0001640334-23-001531-index.html Edgar Link pending
0001640334-23-001531.txt Edgar Link pending
0001640334-23-001531-xbrl.zip Edgar Link pending
bdpt-20230630.xsd Edgar Link pending
bdpt_10q.htm Edgar Link pending
bdpt_10qimg1.jpg Edgar Link pending
bdpt_ex311.htm Edgar Link pending
bdpt_ex312.htm Edgar Link pending
bdpt_ex321.htm Edgar Link pending
bdpt_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
bdpt-20230630_cal.xml Edgar Link unprocessable
bdpt-20230630_def.xml Edgar Link unprocessable
bdpt-20230630_lab.xml Edgar Link unprocessable
bdpt-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bdpt_10q_htm.xml Edgar Link completed
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending